These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3065019)

  • 1. In vitro influence of charcoal on ciprofloxacin activity.
    Torre D; Sampietro C; Quadrelli C; Bianchi W; Maggiolo F; Ohnmeiss H
    Drugs Exp Clin Res; 1988; 14(5):333-4. PubMed ID: 3065019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
    Zeiler HJ; Petersen U; Gau W; Ploschke HJ
    Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation of the effects of efflux pump inhibitors on ciprofloxacin MIC values of high level fluoroquinolone resistant Escherichia coli clinical isolates].
    Coban AY; Birinci A; Ekinci B; Durupinar B
    Mikrobiyol Bul; 2004; 38(1-2):21-5. PubMed ID: 15293898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
    Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
    Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R; Ravagnan G
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
    Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
    Wojnicz D; Jankowski S
    Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physicochemical and antibacterial properties of ciprofloxacin-Mg2+ complex.
    Adepoju-Bello AA; Coker HA; Eboka CJ; Abioye AO; Ayoola GA
    Nig Q J Hosp Med; 2008; 18(3):133-6. PubMed ID: 19062475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
    Parte AC; Smith JT
    Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and antibacterial activity of N-(aroylalkyl) ciprofloxacin].
    Hu AX; Wang YT; You TB
    Yao Xue Xue Bao; 2007 Aug; 42(8):854-7. PubMed ID: 17944234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates.
    Webber MA; Talukder A; Piddock LJ
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4390-2. PubMed ID: 16189130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro susceptibility and emergence of mutants resistant to ciprofloxacin among multidrug resistant clinical isolates.
    Lopes CA; Mendes RP; Curi PC; Watanabe DS; Decarlis RM; Horácio A; Michelin LA; Placidelli BA
    Rev Latinoam Microbiol; 1993; 35(4):345-9. PubMed ID: 8066328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of charcoal on ciprofloxacin activity.
    Torre D
    Rev Infect Dis; 1988; 10(6):1231. PubMed ID: 3206065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.